Heleen Verlinden

Heleen has more than 10 years of experience in R&D, drug discovery, and clinical development in academina and the pharmaceutical industry.

Prior to joining Muna, she coordinated small molecule, biologics, and antibody programs in oncology, and infectious and autoimmune diseases at SGS and Aelin Therapeutics.